A 30-year-old man was admitted to his local hospital because of a history of several months of night sweats, a 20-pound weight loss, anorexia, malaise, and increasing shortness of breath. After the patient was given a short course of oral cephalexin, a chest x-ray revealed a right pleural effusion and a large mediastinal mass. A thoracentesis yielded 1500 cc of bloody fluid. Cytology was not diagnostic.
and his edema cleared. During that admission for approximately 2.5 weeks, 4000 rads were administered in a mantle pattern, and he continued to receive allopurinol.
Ten weeks later the patient was hospitalized for the third time with gross hematuria and bilateral flank discomfort. On examination he was afebrile with a blood pressure of 135/85 mm Hg. He did not have palpable lymphadenopathy, and his abdomen was soft with normal bowel sounds. A large, irregular mass was palpable in the right flank as was a smaller irregular mass in the left flank. The liver and speen could not be palpated.
Laboratory examination revealed serum sodium, 141 mEq; potassium, 4.8 mEq; chloride, 102 mEq; and bicarbonate, 26 mEq/ liter; and BUN, 39 mg; serum creatinine, 3.6 mg; calcium, 9.4 mg; phosphorus, 5.6 mg; and uric acid, 7 mg/dl. The hemoglobin was 11.4 g/dl, and the white blood count was 8600 cells/mm3. Urinalysis revealed a specific gravity of 1.009, a pH of 6, 1+
protein, trace glucose, 5 to 10 white blood cells/high power field, red cells per high-power field too numerous to count, and I to 2 fine granular casts/low-power field. No cellular casts were noted. School, Boston, Massachusetts): To summarize the case, we have a 30-year-old man who, after several months of fever and weight loss, was found to have a bloody pleural effusion and a mediastinal mass with superior vena cava syndrome. Two biopsies were attempted but neither yielded a diagnosis. Following a brief course of radiotherapy for presumed lymphoma, the patient was rehospitalized with leg edema, which responded to conservative treatment.
He received more radiation. Two and one-half months later, while still being treated with allopurinol, he was again hospitalized, this time with flank pain and hematuria. He had developed renal in-sufficiency with a serum creatinine of 3.6 mgldl.
Renal echography revealed large kidneys but no obstruction. A kidney biopsy apparently led to a diagnosis.
Lymphoma patients can develop renal failure in several ways (Table 1 ). The lymphoma can directly obstruct, infiltrate, or cause rupture of various portions of the urinary tract. It can interfere indirectly with renal function by causing hypercalcemia or paraproteinemia, or it can lead through an immunologic route to amyloidosis or glomerulonephritis. Finally, the kidneys can be damaged as a result of treatment directed to lymphoma. I will discuss these mechanisms in detail while attempting to determine the processes that occurred in this patient.
Probably the most common means by which lymphoma leads to renal failure is retroperitoneal obstruction of both ureters. In the very large series of patients reported by Richmond et al, 4% of 696 patients with malignant lymphoma had evidence of bilateral ureteral obstruction [1] . Obstruction also was quite common in the series reported by Wentzell [2] and that of Martinez-Maldonado [3] . The obstruction can result from direct compression of the ureters by enlarging retroperitoneal lymph nodes, by tumor invasion of the ureters themselves, or by retroperitoneal fibrosis. Each of these processes would be expected to produce gradual obstruction of the ureters and lead to an appreciable degree of dilation of the renal pelvis and calyces. The ultrasound study in our patient, however, did not demonstrate distention of these structures. Since a normal ultrasound examination reliably excludes moderate to severe dilation [4] , we can conclude that his renal failure probably did not result from ureteral obstruction by lymphoma, [5, 6] . The bilateral pain, normal echographic findings, and continued good urine output all point away from this possibility.
In addition to the direct physical effects that lymphoma can produce on the urinary tract, renal function can be impaired indirectly by hypercalcemia, tumor products, or tumor antigens. Hypercalcemia, which can result from direct bone invasion, release of parathyroid hormone-like peptides by the tumor, or the effects of prostaglandins, frequently occurs in patients with lymphoma. Such hypercalcemia can lead to nephrocalcinosis and renal failure [7] . At the time this patient was hospitalized with an elevated serum creatinine level, however, the serum calcium was within the normal range. In so-called "myeloma kidney," distal tubules and collecting ducts are filled with casts containing monoclonal paraprotein or light chains that damage the adjacent tubular epithelial cells and interstitium. This condition has been found not only in patients with multiple myeloma but also occasionally in those with malignant lymphoma [8] . The degree of damage correlates roughly with the quantity of light chains in the urine (Bence-Jones proteinuria). Only I + proteinuria was recorded during this patient's third admission; thus this diagnosis seems unlikely. It should be noted that if urinary protein is estimated by the use of the "dipstick" technique, light chains can be overlooked: the dipstick method for detecting protein depends on the ability of certain proteins such as albumin to effect a change in apparent activity coefficient and hence the pH of an indicator dye [9, 10] . This effect results in the indicator having one color in the absence of protein and another color in its presence. Light chains do not have this effect [11] . I hope therefore that the dipstick quantitative test was checked by a sulfosalicylic acid or heatacetic acid technique.
DR. HARRINGT0N: Electrophoresis of both serum and urine revealed no paraprotein. DR. C000INs: Those studies make myeloma kidney unlikely. What about amyloidosis? Although amyloid of the kidneys occurs more frequently as a complication of multiple myeloma or as a "primary" event, it also occurs in some patients with lymphoma-particularly in those with Hodgkin's disease. It has been detected in from 3% to 10% of such patients [12] . Amyloid infiltration would be consistent with our patient's large-sized kidneys and elevated serum creatinine, but it would be an unlikely cause for the very rapid rate of kidney growth and the modest proteinuria.
Glomerular injury has been associated with a number of different kinds of malignant tumors [13] .
In many cases the damage appears to result from deposition of immune complexes containing tumorrelated antigens. Although membranous, membranoproliferative, focal, and crescentic glomerulonephritis have been reported in patients with lymphomas [14] , a much more frequent finding is the clinical picture of nephrotic syndrome with accompanying "minimal change" histopathology and no evidence of immunoglobulin deposition. Whereas an infectious agent, possibly a virus, could cause both the lymphoma and the glomerular disease, or a tumor-specific antigen might become deposited in the glomerulus and lead to damage, it seems more likely that the minimal change lesion results in some way from an abnormality in T-cell function with a defect in delayed hypersensitivity. It has been postulated that an IgE-mediated mechanism might be involved [15] . In this patient, however, we have no clear evidence of nephrotic syndrome, and the minimal proteinuria present during the final admission would argue against primary glomerular injury. Renal failure in a patient with lymphoma often results not from the disease but from the therapy administered. Chronic radiation nephritis as a cause of both glomerular and interstitial disease has been recognized for many years and can occur when both kidneys have received a dose in excess of 2300 rads [16] . Signs and symptoms usually appear 6 to 12 months after the radiotherapy; proteinuria and hypertension appear first and are followed by slowly progressive renal insufficiency. In our patient today, the rapid course and large kidneys do not seem consistent with this diagnosis.
The last categories of treatment-associated renal failure are related to pathways of purine metabolism and excretion. The final metabolites of purines both of endogenous nucleic acid and of dietary origin are shown in Fig. 1 . Normally a fraction of hypoxanthine is "salvaged" for reuse by means of the enzyme hypoxanthine-guanine phosphoribosyl transferase (HPRT). The remainder is transformed to xanthine and thence to uric acid through the action of the enzyme xanthine oxidase. Uric acid, the end of the pathway, is the substance excreted in the urine in humans. When patients with lymphoma are treated with radiation or with cytotoxic agents, the rapid breakdown of cells can result in excessive uric acid production and excretion. When the urine volume is low, as in a dehydrated patient, the excreted urate concentration becomes very high; when the urine is acid, the bulk of urate is excreted in the form of the relatively insoluble uric acid. Thus, when the urine is acidic and concentrated, uric acid can precipitate in the distal tubules and collecting ducts and cause acute renal failure [17] . When the release of uric acid from tissues occurs more slowly, uric acid stones can form in the renal pelvis and occasionally lead to ureteral obstruction.
The drug allopurinol, a structural analogue of hypoxanthine, is converted to oxypurinol, an analogue of xanthine, by xanthine oxidase. Both allopurinol and oxypurinol bind tightly to and are inhibitors of xanthine oxidase; they thus slow the hypoxanthine-xanthine-uric acid transformations. In normal people, treatment with allopurinol leads to an increased fraction of hypoxanthine salvaged" through the HPRT pathway and therefore to a reduction in total oxypurine excretion. Thus, allopurinol given as routine therapy for patients undergoing radiation or cytotoxic chemotherapy for lymphoma virtually eliminates subsequent uric acid uropathy. The serum uric acid level of 7 mg/dl in our patient strongly suggests that uric acid precipitation in the kidney is not the cause of his renal insufficiency. It should be noted, however, that both xanthine and oxypurinol are also relatively insoluble, especially in acidic urine. Monkeys given large doses of allopurinol develop oxypurinol crystal deposits in their kidneys [18] . Pigs who receive oral guanine have increased purine excretion; when these animals are treated with allopurinol, renal deposits of mixed xanthine and oxypurinol are produced [19] . Xanthine crystalluria and calculus formation is a well-known complication in patients with hereditary absence of xanthine oxidase, but recently some allopurinol-treated patients without this hereditary condition were found to form similar crystal deposits or stones [20] . During treatment of lymphoma, the breakdown of large amounts of nucleic acid or an increase in purine excretion comparable to that occurring in patients with hereditary partial defi- nisms that can produce renal failure in a patient with a lymphoma can be regarded as quite unlikely in the patient described here. The ultrasound findings negate ureteral obstruction. The small amount of proteinuria discredits renal vein thrombosis, amyloidosis, or glomerulonephritis. The patient had no evidence of rupture of the renal pelvis or ureter. Serum calcium was normal. Bence-Jones proteinuria was not present, so "myeloma kidney" is unlikely. The time interval between treatment and renal insufficiency was too short for radiation nephritis, and the normal uric acid levels make uric acid uropathy unlikely. This leaves xanthine or oxypurinol precipitation-admittedly a rare event-or renal failure from tumor infiltration of the kidneys as the remaining possible explanations for the renal failure in this patient. I would now like to discuss the latter situation in some detail. Lymphomatous infiltration of the kidneys, a common finding at autopsy, occurs in 6% to 60% of patients [22] , but it is extremely uncommon for the infiltrate to replace functioning renal tissue so completely as to cause renal failure. Significant renal failure occurred in only 0.5% of patients in the large series previously mentioned [1] . Three other clinical reports are of interest. In 6 patients with lymphoma complicated by acute renal insufficiency who were encountered over a 6-year period in a Paris dialysis unit, a variety of histologic findings were noted [23] . In another report of a single patient, the initial presentation of a lymphocytic lymphoma was renal and the diagnosis was established by renal biopsy [24] . Finally, in a third report, a renal arteriogram led to the diagnosis of renal infiltration by lymphoma [25] . The tumor was hypervascular with vessels stretched over and through the infiltrating lesion. Since a good quality grayscale ultrasound examination can distinguish between the pattern of renal cortex and the more echo-free medulla, and since lymphomatous tissue in the kidney can change this pattern, further details of the ultrasound findings might help us in reaching a diagnosis in this patient. The finding of massive lymphomatous involvement of both kidneys would not assure us of the cause of renal failure, however, since kidneys can be massively involved and often still maintain relatively normal function. The diagnosis of renal failure secondary to lymphomatous infiltration must be made by ruling out, as I have tried to do today, other causes of renal failure.
We are left in the uncomfortable position of choosing between two rare causes of renal insufficiency. Infiltration of the kidneys by lymphoma is present. Whether this infiltration is the cause of the renal insufficiency is questionable, but no better alternative is available, so I will posit that as the likely diagnosis. The precipitation of xanthine, oxypurinol, or a combination of the two as a cause of acute renal failure-particularly if the patient is found to have a partial deficiency of HPRT-remains a possibility, as does involvement of the renal vasculature by lymphoma, although we have no specific clues leading us to either of these diagnoses.
The type of lymphoma also is undetermined. In a patient such as ours who has no peripheral adenoinhibits Xanthine Allopurinol pathy and no splenomegaly, one might ask whether the basic diagnosis is lymphoma at all. In this dilemma I hope we are helped by the title of the case presentation, 'Renal Failure in Lymphoma." Since the presentation and progression of the patient as described are consistent with lymphoma, I suppose it is safe to stick with that diagnosis. Of the various types of lymphoma, Hodgkin's disease can produce all the changes seen here, although the apparently sudden airway compromise is somewhat unusual for this relatively slowly progressing lesion.
Lymphoblastic lymphoma is a common cause of mediastinal masses and superior vena cava syndrome in children but not in adults. In addition, by the time lymphoblastic lymphoma spreads to the inferior vena cava and kidneys, it usually has progressed to a leukemic state. Diffuse histiocytic (large cell) lymphoma is more common in adults, can spread rapidly, and can cause the clinical features present in our patient. I would guess that this is the most likely lesion, and that the next most likely is Hodgkin's disease. I am puzzled but delighted that a kidney biopsy apparently led to the diagnosis when two biopsies of the mediastinal mass were nondiagnostic.
In summary, I would say that the patient has lymphoma with bilateral renal infiltration. The renal failure could have resulted from either tumor infiltration directly or from precipitation of xanthine or xanthine-oxypurinol crystals. If forced to pick one diagnosis, I favor the first possibility. tonate renal scan revealed good flow to both kidneys but cortical filling defects were noted bilaterally, and were more extensive on the right. The four-day gallium-67 citrate scan showed marked radionuclide uptake bilaterally, again greater on the right than on the left.
DR. COGGINS: That information tells us that the kidneys are likely affected by lymphoma but it still does not tell us whether that involvement is responsible for the loss of renal function. As I pointed out earlier, a very good quality gray-scale ultrasound examination can distinguish between renal cortex and medulla, and characteristic abnormalities might be found in patients with lymphomatous infiltration within the kidney. I suspect, however, that neither of these occurrences would have been convincingly diagnostic, and I would have proceeded with a kidney biopsy. diffuse dense infiltration of the renal parenchyma by malignant lymphoma. Most of the normal renal architecture is obliterated and only an occasional gbmerulus or tubular profile is identifiable (Fig. 2A) . The tumor cells comprising the infiltrates are large lymphoid cells with pleomorphic nuclei and ample cytoplasm. Many of the tumor cell nuclei exhibit multiple deep clefts resulting in a lobulated or convoluted nuclear shape (Fig. 2B) . Electron micrographs of the tumor cells demonstrate this convoluted nuclear morphology even more clearly (Fig.  2C) . No crystalline deposits were noted in the kidney, and the immunofluorescent studies for IgG, IgA, 1gM, C3, C4, and fibrinogen were negative. were negative in this patient.
The two mediastinal biopsies obtained after radi- ation therapy showed only necrosis, fibrosis, and radiation effects. No identifiable tumor was noted. Two bone marrow biopsies also were obtained, one before and one after this patient's renal deterioration. Both showed no evidence of lymphoma. Lymphoblastic lymphomas of convoluted T-cell type represent a distinct clinicopathologic entity with the following characteristic features: high incidence in older children and adolescents; a high male-to-female ratio; frequent presence of mediastinat tumors at the time of diagnosis: and early bone marrow involvement, which frequently is associated with a leukemic blood picture either early in the course of the disease or at its terminal stages [34] .
DR. DAVID BUSHINSKY (Renal Fellow, NEMCH): Dr. Ucci, we recognize that more tissue would have been required to obtain confirmation of T-cell markers. It was the joint opinion of the Oncology and Renal Services, however, that a specific diagnosis could be made rapidly and that therapy could be instituted using the information obtainable from percutaneous kidney biopsy alone. The combination of large kidneys as demonstrated by physical examination and ultrasound, the absence of obstruction and other reversible causes of renal failure, and the rapidity of the progressive renal ogy Division, NEMCH): I know this patient well because I have been caring for him since the onset of his illness. His was a most unusual and difficult case, as we were forced to irradiate his mediastinal tumor before a definitive tissue diagnosis could be made. Although therapeutic radiation often allows us to win the battle, that is, to relieve the vena cava obstruction, it can cause us to lose the war because histologic diagnosis at biopsy is often precluded after radiation, even if as little as 800 to 1200 rads have been delivered. In this patient, the definitive diagnosis was made when the patient relapsed. I thought he had either lymphoblastic or histiocytic lymphoma when I first examined him but could not be sure. We elected to treat him initially with radiation after exhausting all hope of arriving at a tissue diagnosis. He first showed evidence of disease progression during radiation treatment and was then rehospitalized for a repeat biopsy. As has been noted, he received radiation to his kidneys and was started on a combination chemotherapy protocol similar in type to current regimens used to treat acute childhood leukemia. With this newer approach, the grim outlook of previous years has been reversed so that most patients who have relatively early disease respond to treatment, and many are long-term disease-free survivors [37] . DR. COHEN: We all were struck by the rapidity of the renal failure and therefore proceeded rapidly with treatment as described. As Dr. Coggins noted, the proof that the lymphomatous infiltration was responsible for the renal insufficiency depended on the patient showing improvement in renal function following appropriate therapy. In addition to the improvement in serum creatinine, a follow-up sonographic examination five months later showed a dramatic decrease in kidney size from approximately 15 toll cm (Fig. 3) .
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